These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36865465)

  • 1. QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties.
    El Fadili M; Er-Rajy M; Imtara H; Noman OM; Mothana RA; Abdullah S; Zerougui S; Elhallaoui M
    Heliyon; 2023 Feb; 9(2):e13706. PubMed ID: 36865465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia.
    El Fadili M; Er-Rajy M; Kara M; Assouguem A; Belhassan A; Alotaibi A; Mrabti NN; Fidan H; Ullah R; Ercisli S; Zarougui S; Elhallaoui M
    Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of novel triazolo-benzodiazepine analogues as antidepressants targeting by molecular docking and ADMET properties prediction.
    Belhassan A; Zaki H; Benlyas M; Lakhlifi T; Bouachrine M
    Heliyon; 2019 Sep; 5(9):e02446. PubMed ID: 31528753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclohexane-1,3-dione Derivatives as Future Therapeutic Agents for NSCLC: QSAR Modeling, In Silico ADME-Tox Properties, and Structure-Based Drug Designing Approach.
    Daoui O; Elkhattabi S; Bakhouch M; Belaidi S; Bhandare RR; Shaik AB; Mali SN; Chtita S
    ACS Omega; 2023 Jan; 8(4):4294-4319. PubMed ID: 36743017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico screening of Fyn kinase inhibitors using classification-based QSAR model, molecular docking, molecular dynamics and ADME study.
    Hang NT; Anh TDH; Thanh LN; Anh NV; Van Phuong N
    Mol Divers; 2024 Jun; ():. PubMed ID: 38886315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Modeling Strategies of Cancer Multidrug Resistance.
    Yalcin-Ozkat G
    Drug Resist Updat; 2021 Dec; 59():100789. PubMed ID: 34973929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico evidence of bitopertin's broad interactions within the SLC6 transporter family.
    de Carvalho GA; Tambwe PM; Nascimento LRC; Campos BKP; Chiareli RA; Junior GPN; Menegatti R; Gomez RS; Pinto MCX
    J Pharm Pharmacol; 2024 Sep; 76(9):1199-1211. PubMed ID: 38982944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
    Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
    Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR, molecular docking, molecular dynamics, and ADME/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl-2 family proteins for targeting U-87 glioblastoma.
    Poustforoosh A; Faramarz S; Nematollahi MH; Hashemipour H; Tüzün B; Pardakhty A; Mehrabani M
    J Cell Biochem; 2022 Feb; 123(2):390-405. PubMed ID: 34791695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing of the N-ethyl-4-(pyridin-4-yl)benzamide based potent ROCK1 inhibitors using docking, molecular dynamics, and 3D-QSAR.
    Ghosh S; Keretsu S; Cho SJ
    PeerJ; 2021; 9():e11951. PubMed ID: 34434664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations.
    El Fadili M; Er-Rajy M; Mujwar S; Ajala A; Bouzammit R; Kara M; Abuelizz HA; Er-Rahmani S; Elhallaoui M
    BMC Chem; 2024 Jul; 18(1):142. PubMed ID: 39085870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR, ADME-Tox, and molecular docking of semisynthetic triterpene derivatives as antibacterial and insecticide agents.
    Daoui O; Mazoir N; Bakhouch M; Salah M; Benharref A; Gonzalez-Coloma A; Elkhattabi S; Yazidi ME; Chtita S
    Struct Chem; 2022; 33(4):1063-1084. PubMed ID: 35345415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties.
    Santora VJ; Almos TA; Barido R; Basinger J; Bellows CL; Bookser BC; Breitenbucher JG; Broadbent NJ; Cabebe C; Chai CK; Chen M; Chow S; Chung M; Crickard L; Danks AM; Freestone GC; Gitnick D; Gupta V; Hoffmaster C; Hudson AR; Kaplan AP; Kennedy MR; Lee D; Limberis J; Ly K; Mak CC; Masatsugu B; Morse AC; Na J; Neul D; Nikpur J; Peters M; Petroski RE; Renick J; Sebring K; Sevidal S; Tabatabaei A; Wen J; Yan Y; Yoder ZW; Zook D
    J Med Chem; 2018 Jul; 61(14):6018-6033. PubMed ID: 29886732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.
    Gao Y; Wang H; Wang J; Cheng M
    J Biomol Struct Dyn; 2020 Sep; 38(14):4119-4133. PubMed ID: 31556340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors.
    Safarizadeh H; Garkani-Nejad Z
    J Mol Graph Model; 2019 Mar; 87():129-143. PubMed ID: 30537643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
    J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.